article thumbnail

Eugia Pharma -Walk-In Interviews for Production/ Warehouse / Quality Assurance/ Quality Control/ Microbiology On 24th Sept’ 2022

Pharma Pathway

Eugia Pharma Specialities Limited is Subsidiary of Aurobindo Pharma Limited, Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Job Description. Email Id: hariprasad.vadlamuri@aurobindo.com / harikrishna.gottumukkala@eugia.co.in.

Pharma 86
article thumbnail

FDA completes inspection of Nexus’ manufacturing facility in US

Pharma Leaders

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticalspharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Supply Chain Planning Can Help Pharma Meet All-Time High Drug Supply Demands

PM360

The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. For pharmaceutical manufacturing, many of these processes are subject to good manufacturing practice (GxP) and oversight by regulatory bodies. drug manufacturers to continue producing generic drugs.

article thumbnail

How one pharma “family business” places patients first

pharmaphorum

Founded in 1935 by Chiesi’s grandfather of the same name, Chiesi Group focuses on respiratory conditions, special care, and on rare diseases, including lysosomal storage disorders and rare haematological and ophthalmological diseases. “An But rare diseases are a particularly important and challenging focus area.

article thumbnail

LAMP assays to enable rapid and sensitive detection of BCC

European Pharmaceutical Review

As a result of the rate of contamination events, simple and rapid detection of BCC in non-sterile pharmaceutical products is critical to ensure consumer safety. BCC includes 24 closely related Burkholderia species commonly found in natural environments that are a public health concern. l) within 30 minutes. Daddy Gaoh et al.